In the BioHarmony Drug Report Database

"Preview" Icon

Deucravacitinib

Deucravacitinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against non-receptor tyrosine-protein kinase TYK2. In addition, it is known to target tyrosine-protein kinase JAK1 and bone morphogenetic protein receptor type-2.

 

Trade Name

 

 

Common Name

 

deucravacitinib
 

ChEMBL ID

 

CHEMBL4435170
 

Indication

 

 

Drug Class

 

Tyrosine kinase inhibitors: janus kinase inhibitors; deuterated compounds

Image (chem structure or protein)

Deucravacitinib structure rendering